A novel biomarker signature to predict aggressive disease in African-American men with prostate cancer.

Authors

null

Kosj Yamoah

Thomas Jefferson University, Philadelphia, PA

Kosj Yamoah , Michael Hiroshi Johnson , Voleak Choeurng , Kasra Yousefi , Zaid Haddad , Robert Benjamin Den , Priti Lal , Michael D Feldman , Adam Dicker , Eric A. Klein , Elai Davicioni , Timothy R. Rebbeck , Edward M. Schaeffer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 24)

DOI

10.1200/jco.2015.33.7_suppl.24

Abstract #

24

Poster Bd #

B16

Abstract Disclosures

Similar Posters

First Author: Francisco M De La Vega

First Author: Joaquin Mateo

Poster

2017 Genitourinary Cancers Symposium

Genomic mechanisms of resistance to neoadjuvant leuprolide plus abiraterone in locally advanced prostate cancer.

Genomic mechanisms of resistance to neoadjuvant leuprolide plus abiraterone in locally advanced prostate cancer.

First Author: Adam G. Sowalsky